Detalles de la búsqueda
1.
A Pilot, Phase II, Randomized, Open-Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab-Paclitaxel to That of Solvent-Based Paclitaxel as the First-Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2-Negative Metastatic Breast Cancer.
Oncologist
; 24(11): e1024-e1033, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31023863
2.
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study.
Breast Cancer Res Treat
; 177(1): 115-125, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152327
3.
Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study.
Breast J
; 25(2): 219-225, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30734437
4.
Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response.
Breast J
; 26(4): 800-802, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31565830
5.
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.
Breast
; 74: 103681, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38377732
6.
Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases.
Cancers (Basel)
; 15(6)2023 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980575
7.
Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors.
Cancers (Basel)
; 15(7)2023 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046661
8.
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
Ther Adv Med Oncol
; 15: 17588359221148921, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36743520
9.
Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature.
Front Oncol
; 13: 1158981, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37213307
10.
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor.
Clin Cancer Res
; 28(6): 1107-1116, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980598
11.
Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments.
Eur J Cancer
; 166: 229-239, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316750
12.
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial.
Breast
; 66: 77-84, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36206609
13.
Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study.
Front Oncol
; 11: 645026, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34307126
14.
Prolonged Responses With Trastuzumab Emtasine Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer Refractory to Trastuzumab and Pertuzumab: Systematic Review of Evidence.
Clin Breast Cancer
; 21(5): 391-398, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33549470
15.
Myocarditis and carotidynia caused by Granulocyte-Colony stimulating factor administration.
Mod Rheumatol Case Rep
; 4(2): 318-323, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33087005
16.
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists.
J Drug Assess
; 8(1): 62-69, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31069129
17.
Pleomorphic lobular carcinoma of the breast with osteoclast-like giant cells: a case report and review of the literature.
Diagn Pathol
; 13(1): 62, 2018 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30153845
18.
Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer.
Oncotarget
; 9(17): 13501-13516, 2018 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29568373
19.
18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.
Clin Cancer Res
; 23(6): 1432-1441, 2017 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27587436
20.
Critically short telomeres and toxicity of chemotherapy in early breast cancer.
Oncotarget
; 8(13): 21472-21482, 2017 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28423524